Primary central nervous system lymphoma in a patient treated with Natalizumab
about
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated EntitiesRisk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisCell Trafficking in Chronic Lymphocytic LeukemiaNew and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.Treating multiple sclerosis with natalizumab.Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.Natalizumab in relapsing-remitting multiple sclerosis.
P2860
Q26781389-A1C9D358-9013-466B-BE51-AEC654A4DE54Q28087414-F20A8760-F3E6-4868-9E60-D45E05425E36Q36115034-3DFE789C-DAFF-4063-AD22-74D22381A8B2Q36748702-CD1C03D5-E362-49F8-8FF2-DE8837B5C19CQ37957123-1BEC86D1-2D75-498B-9877-719C3FECDFF1Q38163046-EC9CF5EF-F581-48FC-A0B9-3B8F415213BDQ38436580-E98478C2-437C-48A9-976E-A869AA6C3079Q38786252-425B8270-6267-47BD-B76E-993F41B5D009
P2860
Primary central nervous system lymphoma in a patient treated with Natalizumab
description
im Februar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 February 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2011
@uk
name
Primary central nervous system lymphoma in a patient treated with Natalizumab
@en
Primary central nervous system lymphoma in a patient treated with Natalizumab
@nl
type
label
Primary central nervous system lymphoma in a patient treated with Natalizumab
@en
Primary central nervous system lymphoma in a patient treated with Natalizumab
@nl
prefLabel
Primary central nervous system lymphoma in a patient treated with Natalizumab
@en
Primary central nervous system lymphoma in a patient treated with Natalizumab
@nl
P2093
P50
P356
P1433
P1476
Primary central nervous system lymphoma in a patient treated with natalizumab
@en
P2093
Bernard De Prijck
Christian Herens
Gael Delrue
Gustave Moonen
Manuel Deprez
Remy Phan-Ba
P304
1060-1; author reply 1061-2
P356
10.1002/ANA.22296
P577
2011-02-16T00:00:00Z